Biotechnology

#Antigen #Biotechnology #Collaboration

Collaboration: discovery against GPCRs, ion channels and transporters 

Swedish biotech company Salipro Biotech has entered into a collaboration and licensing agreement with AbCellera for access to its proprietary Salipro Platform, which stabilises challenging G protein coupled receptor (GPCR), ion channel and transporter antigens.  “We are excited to build on the success of our previous studies and deepen our relationship with the team at AbCellera,”… Read More

#News

#Alzheimer's #Biotechnology #Covid-19 #Research

How has the pandemic impacted Alzheimer’s research? 

Sara Imarisio, Head of Strategic Initiatives at Alzheimer’s Research UK, reveals what dementia research could deliver and how Alzheimer’s research can help us re-imagine a future in which lives are saved.  Alzheimer’s and other forms of dementia have been impacted by Covid-19. With many labs forced to close during lockdown, and social… Read More

#Editor's Choice #Exclusive Content #News #Opinion

#Biotechnology #Pharma #Pharmacovigilance #Regulatory

Listicle: Experts on the differences between FDA and EMA regulations

Biotechs involved in drug discovery have to navigate increasingly complex regulatory environments across borders. Experienced experts and non-executive advisors to Arriello, Eric Caugant, Principal Consultant at Pharmacovigilance Systems Consulting & Board advisor to Arriello, and Judi Sills, JM Sills Consulting & Board advisor to Arriello, highlight the main differences between US… Read More

#Listicles #News #Sponsored Content #Videos

#Biotechnology #Collaboration #Data #Technology #Webinar

Webinar reveals how to accelerate your drug discovery program 

This free-to-watch webinar, brought to you by Certara, reviews best practices for using technology to overcome challenges in order to accelerate discovery programs.  Drug discovery research requires understanding complex chemical, biological, logistical, and computational data from a variety of data sources. A key challenge for discovery scientists is efficiently accessing the most… Read More

#Intelligence #News #Trends & Analysis

#Biopharma #Biotechnology #Collaboration #Life sciences #Technology

Why quantum computing in drug discovery needs to improve  

The Pistoia Alliance has released new results from a survey of 260 attendees from life science companies across the globe, finding that almost half classify their understanding of quantum computing (QC) technology at the beginner level (48%) only. This is followed by intermediate (29%), advanced (13%), and expert at 9%. Read More

#News #Trends & Analysis

#Biotechnology #Clinical trials #Research

Women’s antibiotic-free treatment trial reaches 50% recruitment 

Swedish company Gedea Biotech has announced that it has enrolled more than 50% of patients in the NEFERTITI clinical study of its lead product, pHyph, a vaginal tablet for topical treatment of bacterial vaginosis (BV). The randomised double-blind placebo-controlled study is designed to confirm the safety and efficacy of pHyph and is coordinated by Nottingham University… Read More

#News

#Biotechnology #Clinical trial #Data #Psychedelics

First patient receives low-dose psilocybin for rare headache disorder 

Beckley Psytech has dosed the first patient in a world-first clinical trial exploring the effects of psilocybin for treating Short-lasting Unilateral Neuralgiform Headache Attacks (SUNHA).   The outcome of the Phase Ib study, with proof-of-concept efficacy data, is expected to be available in early 2022. The clinical trial is being… Read More

#News

#Biotechnology #Life sciences

Lithuania eyes major window of opportunity in life sciences 

Enterprise Lithuania and the Lithuanian Biotechnology Association has announced that in 2020, the Lithuanian biotechnology sector grew by a record 87% and accounted for 2.5% of the Baltic nation’s GDP. Industry leaders gathering at the upcoming Life Sciences Baltics forum are now calling for more international collaborations, increased investment and… Read More

#Market Reports #News #Trending News

#Biotechnology #Clinical trials #CRISPR #Market reporting #Therapeutics

Report predicts trends and forecasts for CRISPR 

The "CRISPR Based Therapeutics Market by Type of Therapy, Therapeutic Approach, Therapeutic Area, and Key Geographical Regions: Industry Trends and Global Forecasts 2021-2030" report has been added to ResearchAndMarkets.com's offering.  The report features a study of the current market landscape and future opportunity for the players involved in the development of CRISPR… Read More

#Business & Investment #Market Reports #News #Trends & Analysis

#Biopharmaceuticals #Biotechnology #Drug innovation

Sciex launches capillary electrophoresis solution

Sciex has launched a capillary electrophoresis solution, the BioPhase 8800 system. The multi-capillary system for CE-SDS processes eight samples simultaneously, retaining sample integrity and delivering consistent results.  The development of biopharmaceutical therapies requires the ability to measure and monitor critical quality attributes in short timelines. The BioPhase 8800… Read More

#News

#AI #Biotechnology #Events #Life sciences #Microbiome #Webinar

Free virtual event on microbiome research 

Microbiome experts from Microba Life Sciences will discuss the next phase of discovery from the microbiome to a global audience via a series of webinars on September 15 (PST 10am-12pm | EST 1-3pm | CET 7pm).  Professor Gene Tyson, Associate Professor Lutz Krause and Dr Alena Pribyl will discuss how advancements in metagenomic… Read More

#News

#Biotechnology #Infographic

Infographic: Biotech hot spots in a fragmented European landscape 

McKinsey has mapped out 1,382 biotechs based in Europe and some interesting themes emerged, showing how European biotechs have established a position of strength from which to enter the industry’s next act. Over the past three years, Europe’s biotech industry has made meaningful progress on attracting capital and bringing products to market.  Europe’s complex biotech… Read More

#Market Reports #News #Trends & Analysis

#AI #Biotechnology #Chemistry #Digital #Drug discovery #Life sciences

Digital Science launches research platform 

Digital Science has launched a new version of its Dimensions platform - Dimensions Life Sciences & Chemistry - focused on life sciences and chemistry research activities.   Dimensions L&C analyses more than 120 million scientific publications, millions of patents, grants and clinical trial documents. It applies semantic text analysis tools and ontologies, providing… Read More

#Business & Investment

#Biotechnology #Collaboration #Training

OGT training initiative with CytoCell University

OGT has expanded its activities with CytoCell University, an initiative that provides training to scientists on the basics of fluorescence in situ hybridisation (FISH). CytoCell University’s FISH training and OGT aim to support scientists internationally and help customers advance genetic analysis. CytoCell University’s first module, set to be part of… Read More

#News

#Biotechnology #Drug discovery #Exscientia #Technology

Exscientia builds automated laboratories to expand pipeline

Exscientia has announced the opening of a 21,000 square foot expansion of its facilities at Oxford Science Park, UK, increasing capacity for its technology teams as well as significantly expanding its laboratory-based experimental capabilities in structural biology, biophysics and high-content pharmacology. In parallel, Exscientia is building a new 26,000 square… Read More

#News #Trending News